These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 786356)

  • 61. [Comparison of the effectiveness of the double blind test and the tolerance of phenylbutazone and indomethacin in a series of patients with chronic progressive polyarthritis].
    Santamaría A; Serra Peralba A; Barceló P; Asensi E; Salvador F
    Rev Esp Reum Enferm Osteoartic; 1968 Jan; 12(5):283-7. PubMed ID: 4904815
    [No Abstract]   [Full Text] [Related]  

  • 62. [Action of butazolidin].
    Serra Peralba A
    Rev Esp Reum Enferm Osteoartic; 1966 Oct; 11(8):335-7. PubMed ID: 5998006
    [No Abstract]   [Full Text] [Related]  

  • 63. [Experience with a combination of phenylbutazone, isopyrin and prednisolone in the treatment of rheumatoid arthritis].
    Rau R
    Med Welt; 1969 Sep; 36():1976-81. PubMed ID: 5809876
    [No Abstract]   [Full Text] [Related]  

  • 64. [Pyrasanone in the treatment of rheumatism].
    Pellegrini P; Colamussi V; Trotta F; Scaramelli M; Bazzanini G
    Minerva Med; 1975 Oct; 66(67):3509-33. PubMed ID: 1103007
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Clinico-immunological analysis of the use of nonsteroid anti-inflammatory agents in rheumatoid arthritis].
    Beneson EV; Alibekova RI; Nemtsov BF; Ualieva TM
    Revmatologiia (Mosk); 1984; (1):38-40. PubMed ID: 6372003
    [No Abstract]   [Full Text] [Related]  

  • 66. [Standardizatin of therapeutic trials of analgesic and antirheumatic drugs].
    Litvoc J; Kehdi D; Mendes SF; Arie WM
    Hospital (Rio J); 1970; 78(5):1327-35. PubMed ID: 4934889
    [No Abstract]   [Full Text] [Related]  

  • 67. [Evaluation of the therapeutic action of flufenamic acid in patients with chronic polyarthritis in a double blind study].
    Mathies H; Eichhorn M
    Med Monatsschr; 1967 Nov; 21(11):510-6. PubMed ID: 4893773
    [No Abstract]   [Full Text] [Related]  

  • 68. Comparison of phenyl- and monophenylbutazone (Mobutazon), especially in respect to the incidence of side effects. A double-blind study.
    Thune S
    Acta Rheumatol Scand; 1967; 13(1):63-80. PubMed ID: 5297943
    [No Abstract]   [Full Text] [Related]  

  • 69. [Therapeutic efficacy and tolerance of a combined phenylbutazone-isopyrin preparation].
    Moll W
    Praxis; 1966 Dec; 55(49):1430-5. PubMed ID: 6013658
    [No Abstract]   [Full Text] [Related]  

  • 70. [Current aspects of rheumatoid arthritis].
    Goebel KM; Hahn E; Hausmann L; Storck U; Kaffarnik H; Neurath F
    Fortschr Med; 1979 Oct; 97(40):1793-8. PubMed ID: 396214
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Clinical evaluation of feprazone in rheumatoid arthritis (author's transl)].
    Shichikawa K; Maeda A; Iwasaki Y
    Ryumachi; 1979 Apr; 19(2):147-63. PubMed ID: 375431
    [No Abstract]   [Full Text] [Related]  

  • 72. [Ketoprofen in rheumatic arthropathies in old age. Double-blind studies].
    Ricciardi S; Filosa E
    Clin Ter; 1977 Dec; 83(6):593-608. PubMed ID: 343974
    [No Abstract]   [Full Text] [Related]  

  • 73. A chronic dose-ranging study of the pharmacokinetics of phenylbutazone in rheumatoid arthritic patients.
    Higham C; Aarons L; Holt PJ; Lynch M; Rowland M
    Br J Clin Pharmacol; 1981 Aug; 12(2):123-9. PubMed ID: 7306426
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Clinical trial of a new phenylalcanoic acid derivative].
    Chériè Lignière G; Colombo B; Carrabba M
    Minerva Med; 1973 May; 64(34):1815-20. PubMed ID: 4578239
    [No Abstract]   [Full Text] [Related]  

  • 75. [2 cases of Lyell's syndrome with a severe course].
    Voborová A; Krtková J
    Cesk Dermatol; 1973 Dec; 48(6):418-23. PubMed ID: 4771786
    [No Abstract]   [Full Text] [Related]  

  • 76. [Clinical evaluation of GP 45 840].
    Shiokawa Y; Taktori M; Sakuma A
    Ryumachi; 1972 Nov; 12(3):271-82. PubMed ID: 4576241
    [No Abstract]   [Full Text] [Related]  

  • 77. [Special problems of anti-rheumatic drug therapy in the aged].
    Kaiser H
    Verh Dtsch Ges Rheumatol; 1978; 5():274-5. PubMed ID: 706679
    [No Abstract]   [Full Text] [Related]  

  • 78. [Undesired effects of phenylbutazone on the hemopoietic, vascular, hematologic and blood coagulation systems].
    Siegmeth W
    Wien Med Wochenschr; 1971 Oct; 121(43):784-90. PubMed ID: 5156870
    [No Abstract]   [Full Text] [Related]  

  • 79. [Comparison of clinical effect and blood concentration of phenylbutazone during long-term treatment].
    Gaucher A; Royer RJ; Netter P; Royer-Morrot MJ; Faure G; Pourel J
    Sem Hop; 1976 Sep 10-20; 52(31-32):1723-4. PubMed ID: 191919
    [No Abstract]   [Full Text] [Related]  

  • 80. Adverse reactions with long-term use of phenylbutazone and oxyphenbutazone.
    Sperling IL
    Lancet; 1969 Sep; 2(7619):535-7. PubMed ID: 4184850
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.